Bryon Rubery, MD
Clinical Cardiac Electrophysiology · Winston Salem, NCNPI 1447297833
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 483 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,734 and has fallen 51.8% since, to $836 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NC, where the typical reported total is $16,673.
Across 483 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Novartis$1K
- Medtronic$731
- AstraZeneca$558
- Cardiva Medical, Inc.$558
- E.r. Squibb & Sons, L.L.C.$545
- plus $3K from 18 others
Across 264 payments — averaging $136.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotronik Inc.$36K
What the payments were for
- Food & beverage$8,601100%
- Education$340%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 103 | $1,850 |
| Novartis | 64 | $1,082 |
| Medtronic(2 entities) | 42 | $731 |
| AstraZeneca | 31 | $558 |
| Cardiva Medical, Inc. | 35 | $558 |
| E.r. Squibb & Sons, L.L.C. | 35 | $545 |
| Amgen | 32 | $543 |
| Abbott | 25 | $525 |
| Biosense Webster, Inc. | 17 | $432 |
| Johnson & Johnson | 28 | $431 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $272 |
| Biotronik Inc. | 12 | $229 |
| Boehringer Ingelheim | 12 | $219 |
| Merck | 6 | $142 |
| Atricure, Inc. | 4 | $134 |
| Vital Connect, Inc | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Pfizer | 3 | $49 |
| ZOLL Respicardia, Inc. | 2 | $38 |
| Heartflow, Inc. | 1 | $34 |
| Novo Nordisk | 2 | $34 |
| Elutia, Inc. | 2 | $34 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
How this compares
$8,634 in reported general payments places this provider in the 25th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
See all clinical cardiac electrophysiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 453 | $439,546 |
| XareltoRivaroxaban | 161 | $178,294 |
| MultaqDronedarone Hcl | 38 | $58,878 |
| EntrestoSacubitril/Valsartan | 26 | $40,096 |
| JardianceEmpagliflozin | 21 | $16,868 |
| Metoprolol Succinate | 572 | $9,638 |
| Dofetilide | 34 | $9,220 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 250 | $5,928 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 11 | $5,583 |
| Flecainide Acetate | 121 | $3,964 |
| Digoxin | 68 | $1,549 |
| Potassium Chloride | 28 | $1,223 |
| Carvedilol | 149 | $1,076 |
| Diltiazem 24hr ErDiltiazem Hcl | 26 | $918 |
| SotalolSotalol Hcl | 41 | $906 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $49 | $439,546453 claims |
| Johnson & JohnsonXarelto | $431 | $178,294161 claims |
| NovartisEntresto | $1,082 | $40,09626 claims |
| Boehringer IngelheimJardiance | $219 | $16,86821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
Other clinical cardiac electrophysiology in Winston Salem
- Lai Chow KokWinston Salem$74K
- Natalie BradfordWinston Salem$57K
- George WaitsWinston Salem$55K
- Prashant BhaveWinston Salem$47K
- Michael DruckerWinston Salem$37K
- Kashif ChaudhryWinston Salem$19K
- Rafael CavalcantiWinston Salem$19K
- Takeki SuzukiWinston Salem$16K
- Nicholas CostaWinston Salem$15K
- Mark MitchellWinston Salem$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.